Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

NCT04674306 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer
TNBC - Triple-Negative Breast Cancer
Residual Disease

Interventions

BIOLOGICAL: α-lactalbumin vaccine
BIOLOGICAL: Zymosan

Sponsor

George T. Budd

Collaborators

[object Object]
[object Object]